QuickView for BRAF;jsessionid=2547D466A978ABBB1602416142B7EAE5;jsessionid=DB8C3B61C62A76DDE4B68BB701ECDB69;jsessionid=CAF857554EE36718F35BD1E228EBC51D;jsessionid=847DDEECCE74996EAADAD668640266AF;jsessionid=5CE9295A4C634A8905F0CB53BAD53AA4;jsessionid=077366826ED128AF7C5727789FFB0390 (gene)

1. Computational analysis of natural product B-Raf inhibitors.
2. Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor.
3. A novel BRAF::PTPRN2 fusion in meningioma: a case report.
4. Recent advances in B-RAF inhibitors as anticancer agents.
5. A B-Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted the…

There were no clinical trials for BRAF;jsessionid=2547D466A978ABBB1602416142B7EAE5;jsessionid=DB8C3B61C62A76DDE4B68BB701ECDB69;jsessionid=CAF857554EE36718F35BD1E228EBC51D;jsessionid=847DDEECCE74996EAADAD668640266AF;jsessionid=5CE9295A4C634A8905F0CB53BAD53AA4;jsessionid=077366826ED128AF7C5727789FFB0390